Inventor · disambiguated record
Huilei Xu
Also filed as: XU HUILEI
6 granted patents·5 pending applications·7 citations·filing 2016–2024
75Inventor score
Files withALNYLAM PHARMACEUTICALS INC11
Top patents by PatentIndex Score
11 records- 0191US11434487B2Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Sep 6, 2022·2 cites·31 claims
- 0291US10767177B2Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Sep 8, 2020·4 cites·59 claims
- 0380US2024294911A1INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0478US10494632B2Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Dec 3, 2019·1 cites·22 claims
- 0577US2023093948A1STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0676US2025019699A1Compositions and methods for inhibiting expression of the lect2 geneALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0774US11066670B2Insulin-like growth factor binding protein, acid labile subunit (IGFALS) and insulin-like growth factor 1 (IGF-1) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Jul 20, 2021·0 cites·17 claims
- 0873US2022042012A1INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0967US11987792B2Compositions and methods for inhibiting expression of the LECT2 geneALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted May 21, 2024·0 cites·20 claims
- 1067US2020291405A1HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1166US10640770B2Hepatitis D virus (HDV) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted May 5, 2020·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Huilei Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →